Global Amoxicillin Antibiotic Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Amoxicillin Antibiotic Market Insights, Forecast to 2034
Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.
Global Amoxicillin Antibiotic market is expected to reach to US$ 4792.5 million in 2024, with a positive growth of %, compared with US$ 4613 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Amoxicillin Antibiotic industry is evaluated to reach US$ 5851.7 million in 2029. The CAGR will be 3.4% during 2024 to 2029.
Global Amoxicillin main players include GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, NCPC, United Laboratories, Sun Pharma, CSPC, LKPC, Hikma, Dr. Reddy, HPGC, Aurubindo, Meiji Holdings, etc., totally accounting for about 48%. Europe is the largest market, with a share over 29%. As for the types of products, it can be divided into capsule, tablet and others. The most common product is capsulee, holding a share over 80%. In terms of applications, it is widely used in hospital pharmacy, retail pharmacy and online pharmacy. The most application is retail pharmac, with a share over 62%.
Report Covers
This report presents an overview of global Amoxicillin Antibiotic market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Amoxicillin Antibiotic market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
United Laboratories
Sun Pharma
CSPC
LKPC
Hikma Pharmaceuticals USA Inc.
Dr. Reddy
HPGC
Aurobindo Pharma
Meiji Holdings
GSK
Novartis
Centrient Pharma
Teva
Mylan
Cipla
NCPC
Segment by Type
Pill
Capsule
Powder
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Amoxicillin Antibiotic plant distribution, commercial date of Amoxicillin Antibiotic, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Amoxicillin Antibiotic introduction, etc. Amoxicillin Antibiotic Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Amoxicillin Antibiotic
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Amoxicillin Antibiotic market is expected to reach to US$ 4792.5 million in 2024, with a positive growth of %, compared with US$ 4613 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Amoxicillin Antibiotic industry is evaluated to reach US$ 5851.7 million in 2029. The CAGR will be 3.4% during 2024 to 2029.
Global Amoxicillin main players include GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, NCPC, United Laboratories, Sun Pharma, CSPC, LKPC, Hikma, Dr. Reddy, HPGC, Aurubindo, Meiji Holdings, etc., totally accounting for about 48%. Europe is the largest market, with a share over 29%. As for the types of products, it can be divided into capsule, tablet and others. The most common product is capsulee, holding a share over 80%. In terms of applications, it is widely used in hospital pharmacy, retail pharmacy and online pharmacy. The most application is retail pharmac, with a share over 62%.
Report Covers
This report presents an overview of global Amoxicillin Antibiotic market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Amoxicillin Antibiotic market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
United Laboratories
Sun Pharma
CSPC
LKPC
Hikma Pharmaceuticals USA Inc.
Dr. Reddy
HPGC
Aurobindo Pharma
Meiji Holdings
GSK
Novartis
Centrient Pharma
Teva
Mylan
Cipla
NCPC
Segment by Type
Pill
Capsule
Powder
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Amoxicillin Antibiotic plant distribution, commercial date of Amoxicillin Antibiotic, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Amoxicillin Antibiotic introduction, etc. Amoxicillin Antibiotic Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Amoxicillin Antibiotic
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports